Literature DB >> 11606034

Interactions of aspirin and salicylic acid with prednisolone for inhibition of lymphocyte proliferation.

R Ramakrishnan1, W J Jusko.   

Abstract

The anti-inflammatory properties of salicylates and prednisolone were investigated using inhibition of in vitro phytohemagglutinin-stimulated lymphocyte proliferation in human whole blood from healthy male and female subjects. Steroids and salicylates are used in conjunction for the treatment of inflammatory disorders such as rheumatoid arthritis and inhibit the proinflammatory transcription factor, NFKB, by different mechanisms. Data generated using various combinations of these drugs were analyzed using isobolograms and the universal surface response approach based on the Loewe additivity principle. The interaction between aspirin and prednisolone was mildly antagonistic while that between salicylic acid and prednisolone was modestly synergistic at therapeutic concentrations. Further, aspirin was slightly more potent in males, but the nature of the steroid-salicylate interaction was similar across genders. This study helps rationalize part of the beneficial effects of steroids and salicylates in treatment of inflammatory disorders.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11606034     DOI: 10.1016/s1567-5769(01)00132-1

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  7 in total

Review 1.  Pharmacokinetic/pharmacodynamic modeling in inflammation.

Authors:  Hoi-Kei Lon; Dongyang Liu; William J Jusko
Journal:  Crit Rev Biomed Eng       Date:  2012

Review 2.  Aminoglycoside- and Cisplatin-Induced Ototoxicity: Mechanisms and Otoprotective Strategies.

Authors:  Corné J Kros; Peter S Steyger
Journal:  Cold Spring Harb Perspect Med       Date:  2019-11-01       Impact factor: 6.915

Review 3.  Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.

Authors:  David Czock; Frieder Keller; Franz Maximilian Rasche; Ulla Häussler
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

4.  Interactions of everolimus and sorafenib in whole blood lymphocyte proliferation.

Authors:  Dipti K Pawaskar; Robert M Straubinger; Gerald J Fetterly; Wen W Ma; William J Jusko
Journal:  Pharm Res       Date:  2012-11-14       Impact factor: 4.200

5.  Aspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas disease.

Authors:  Shankar Mukherjee; Fabiana S Machado; Huang Huang; Helieh S Oz; Linda A Jelicks; Cibele M Prado; Wade Koba; Eugene J Fine; Dazhi Zhao; Stephen M Factor; J Elias Collado; Louis M Weiss; Herbert B Tanowitz; Anthony W Ashton
Journal:  PLoS One       Date:  2011-02-15       Impact factor: 3.240

Review 6.  Aspirin and age related macular degeneration; the possible relationship.

Authors:  Yan Wu; Wei Zhu; Yan-Hong Li; Jing Yu
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2013

7.  Aspirin use associated with amyotrophic lateral sclerosis: a total population-based case-control study.

Authors:  Ching-Piao Tsai; Feng-Cheng Lin; Johnny Kuang-Wu Lee; Charles Tzu-Chi Lee
Journal:  J Epidemiol       Date:  2014-12-27       Impact factor: 3.211

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.